about
Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis.Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulationAlemtuzumab treatment alters circulating innate immune cells in multiple sclerosis.B7-H1 shapes T-cell-mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity.Reply to Liu et al.: Haplotype matters: CD226 polymorphism as a potential trigger for impaired immune regulation in multiple sclerosis.Analysis of Lymphocyte Extravasation Using an In Vitro Model of the Human Blood-brain Barrier.Generation of a Model to Predict Differentiation and Migration of Lymphocyte Subsets under Homeostatic and CNS Autoinflammatory ConditionsFulminant MS Reactivation Following Combined Fingolimod Cessation and Yellow Fever VaccinationCD8+ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndromeIntegrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis
P50
Q36429919-06A80A5F-9F07-4114-9B52-EC4BD67A0363Q36957280-D0B58CA0-67E4-4A7C-978E-66A99DDF75A1Q37337775-4742D87E-F8FB-4AD5-BAEC-45FD0575F491Q37346789-126E9575-8127-4BFE-BF31-85DE8787467DQ41785267-E8D839D4-56DC-426D-A881-7CC4DF022A6EQ50177856-944D1B8E-A930-4613-ABD0-7DF12EDDF925Q90461218-3421CCB4-6C69-404D-BE9F-FC74AB5815CAQ91642669-FC6134D1-7619-4D29-AB21-106273E8FDFEQ92096342-7008F19F-3CB9-46C3-B1D8-0E6DA1DCF6CFQ92642889-3BB6FEFB-4F28-4E3D-BEA0-F6A2DD17FA9E
P50
description
researcher (ORCID 0000-0003-3855-4706)
@en
wetenschapper
@nl
name
Andreas Schulte-Mecklenbeck
@en
Andreas Schulte-Mecklenbeck
@nl
type
label
Andreas Schulte-Mecklenbeck
@en
Andreas Schulte-Mecklenbeck
@nl
prefLabel
Andreas Schulte-Mecklenbeck
@en
Andreas Schulte-Mecklenbeck
@nl
P31
P496
0000-0003-3855-4706